← Eichor
Study identifier: NCT05486546 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Condition: Myopia · Astigmatism  ·  Sponsor: Daniel Terveen

PhaseNA
Planned participants120
Who can joinAll sexes, 21 Years to 38 Years
Healthy volunteersNo

About this study

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Terveen, MD  ·  605-645-7999  ·  daniel.terveen@vancethompsonvision.com

Elise Meide, M.S.  ·  605-645-0444  ·  elise.reid@coyotes.usd.edu

Always discuss trial participation with your own doctor first.

Locations (4)

Vance Thompson VisonBozeman, Montana, United StatesRecruiting
Vance Thompson VisionOmaha, Nebraska, United StatesRecruiting
Vance Thompson VisionFargo, North Dakota, United StatesRecruiting
Vance Thompson VisionSioux Falls, South Dakota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05486546